建发致新 (301584)

Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd.

ASZ

Tags

New QFII HoldingsPharmaceuticals and HealthcarePharmaceutical CommerceSmart HealthcareIntelligent MachinesNew Private Equity HoldingsHigh Accounts ReceivableShenzhen Recently Listed StocksChiNext Composite IndexShanghai LocalWholesale & Retail IndexShanghai

K-Line Chart

No K-line data available

Company NameShanghai C&D Zhixin Medical Technology Group Co., Ltd.
Listing Date2025-09-25
Issue Price7.05RMB
Registered Capital42128.850910k RMB
Legal RepresentativeYu Feng
Registered Address9th Floor, No. 288 Yangshupu Road, Yangpu District, Shanghai
IndustryPharmaceutical Commerce
Main BusinessDirect sales and distribution of medical devices, and providing centralized operation (SPD) services for medical consumables to end hospitals.
Company ProfileShanghai C&D Zhixin Medical Technology Group Co., Ltd., as a national high-value medical device distributor, is primarily engaged in the direct sales and distribution of medical devices, and provides centralized operation (SPD) services for medical consumables to end hospitals. In the medical device industry chain, the company mainly undertakes the circulation function of medical devices, serving as a hub connecting manufacturers, distributors, and end medical institutions, playing a crucial role in linking upstream and downstream segments. Based on the characteristics of high-value medical devices, the company actively promotes the application of information management in traditional medical device circulation business and provides centralized operation (SPD) services for medical consumables to end hospital clients, further empowering services across the industry chain. Leveraging its self-developed Zhixin Chain intelligent medical consumables management software, the company actively expands its SPD business, having signed contracts for centralized operation services of medical consumables with 7 hospitals. In 2021, it was selected by the Medical Device Supply Chain Branch of the China Federation of Logistics & Purchasing as a "Pilot Unit for the Group Standard T/CFLP 0023-2019 'Specification for Hospital In-house Logistics Services of Pharmaceutical Products'."

Stock Details

1. Key Indicators

  • Total Shares(W): 42128.85
  • Circulating A-Shares(W): 5042.39
  • Earnings Per Share(RMB): 0.6400
  • Net Assets Per Share(RMB): 4.9306
  • Operating Revenue(W RMB): 1486075.39
  • Total Profit(W RMB): 38972.62
  • Net Profit Attributable to Parent(W RMB): 22983.35
  • Net Profit Growth Rate(%): 45.01
  • Weighted Return on Equity(%): 14.3800
  • Operating Cash Flow Per Share(RMB): 0.1200
  • Undistributed Profit Per Share(RMB): 2.9388
  • Capital Reserve Per Share(RMB): 0.8099

2. Main Business

The main business covers:

  • Medical device direct sales and distribution business
  • Providing services such as intensive operation of medical consumables (SPD)

3. Company Basic Information

  • Company Name: Shanghai C and D INNOSTIC Medical Technology Group Co., Ltd.
  • Listing Date: 2025-09-25
  • Industry: Medicine and Medical - Medical Business (Wholesale)
  • Address: 9th Floor, No. 288 Yangshupu Road, Yangpu District, Shanghai
  • Website: www.innostic.com
  • Company Profile: The issuer was established as a joint stock company through the overall change of Zhixin Co., Ltd. On September 23, 2017, Dahua Certified Public Accountants (Special General Partnership) issued the "Dahua Audit No. [2017] 008019" "Audit Report". According to the report, the net asset value of Zhixin Co., Ltd. as of July 31, 2017 was 356,934,057.17 yuan. On September 25, 2017, Shanghai Dongzhou Asset Appraisal Co., Ltd. issued the "Hudongzhou Asset Appraisal Report No. [2017] 1032" "Evaluation Report on the Net Assets of the Enterprise Involved in the Planned Restructuring of Shanghai Zhixin Medical Supply Chain Management Co., Ltd. into a Joint Stock Company". According to the report, the assessed value of the net assets of Zhixin Co., Ltd. as of July 31, 2017 was 358,092,943.41 yuan. On September 25, 2017, Zhixin Co., Ltd. held a shareholders' meeting, and all shareholders unanimously agreed to change Zhixin Co., Ltd. into a joint stock company. On October 10, 2017, the shareholders of Zhixin Co., Ltd., Pingxiang Changheyuan, Pingxiang Qingshi, Shanghai Aixiang, Xinyu Zhiyu, Tibet Zhenshan, and Gu Minniu, as promoters, jointly signed the "Promoter Agreement" and unanimously agreed to establish the company by way of promotion. On the same day, Zhixin Co., Ltd. held the founding meeting and shareholders' meeting, agreeing to establish the company by way of promotion. Based on the audited net asset value of Zhixin Co., Ltd. as of July 31, 2017, which was 356,934,057.17 yuan, it was converted into 200 million shares of the joint stock company at a ratio of 1:0.5603, and the remaining 156,934.057.17 yuan that was not converted into shares was included in the capital reserve of the joint stock company. On November 8, 2017, the Shanghai Administration for Industry and Commerce issued the "Business License" to the company. Unified Social Credit Code: 91310104560199492F.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 J. P. Morgan Securities PLC-自有资金 QFII 48.85 0.97
2 高盛公司有限责任公司 QFII 34.25 0.68
3 MERRILL LYNCH INTERNATIONAL QFII 26.31 0.52
4 深圳前海道谊投资控股有限公司-道谊金量股票优选1号私募证券投资基金 Private Securities Investment Fund 19.15 0.38
5 MORGAN STANLEY & CO. INTERNATIONAL PLC. QFII 17.18 0.34
6 建信央视财经50指数证券投资基金(LOF) Fund 0.45 0.01
7 交银施罗德创业板50指数型证券投资基金A类 Fund 0.45 0.01
8 交银施罗德国证新能源指数证券投资基金(LOF)A类 Fund 0.45 0.01
9 交银施罗德中证红利低波动100指数型证券投资基金A类 Fund 0.45 0.01
10 鹏华创业板50交易型开放式指数证券投资基金 Fund 0.45 0.01

5. Concept Sectors

  • Newly Listed Stock
  • Intelligent Machine
  • Intelligent Medical Care
  • Margin Trading & Securities Lending
  • QFII New Entry
  • High Accounts Receivable
  • Private Placement New Entry
  • Shenzhen Newly Listed Stock Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information